These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28722474)

  • 1. When will small molecule lactate dehydrogenase inhibitors realize their potential in the cancer clinic?
    Rani R; Kumar V
    Future Med Chem; 2017 Jul; 9(11):1113-1115. PubMed ID: 28722474
    [No Abstract]   [Full Text] [Related]  

  • 2. Targeting cancer metabolism to develop human lactate dehydrogenase (hLDH)5 inhibitors.
    Zhang SL; He Y; Tam KY
    Drug Discov Today; 2018 Jul; 23(7):1407-1415. PubMed ID: 29750903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Update on Human Lactate Dehydrogenase Enzyme 5 (hLDH5) Inhibitors: A Promising Approach for Cancer Chemotherapy.
    Rani R; Kumar V
    J Med Chem; 2016 Jan; 59(2):487-96. PubMed ID: 26340601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-aided discovery and biological characterization of human lactate dehydrogenase 5 inhibitors with anti-osteosarcoma activity.
    Cao W; Fang L; Teng S; Chen H; Wang Z
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2229-2233. PubMed ID: 29861142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of lactate dehydrogenase activity as an approach to cancer therapy.
    Fiume L; Manerba M; Vettraino M; Di Stefano G
    Future Med Chem; 2014 Mar; 6(4):429-45. PubMed ID: 24635523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual targeting of the Warburg effect with a glucose-conjugated lactate dehydrogenase inhibitor.
    Calvaresi EC; Granchi C; Tuccinardi T; Di Bussolo V; Huigens RW; Lee HY; Palchaudhuri R; Macchia M; Martinelli A; Minutolo F; Hergenrother PJ
    Chembiochem; 2013 Nov; 14(17):2263-7. PubMed ID: 24174263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Hydroxyindole-based inhibitors of lactate dehydrogenase against cancer cell proliferation.
    Granchi C; Roy S; De Simone A; Salvetti I; Tuccinardi T; Martinelli A; Macchia M; Lanza M; Betti L; Giannaccini G; Lucacchini A; Giovannetti E; Sciarrillo R; Peters GJ; Minutolo F
    Eur J Med Chem; 2011 Nov; 46(11):5398-407. PubMed ID: 21944286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the first highly selective inhibitor of human lactate dehydrogenase B.
    Shibata S; Sogabe S; Miwa M; Fujimoto T; Takakura N; Naotsuka A; Kitamura S; Kawamoto T; Soga T
    Sci Rep; 2021 Nov; 11(1):21353. PubMed ID: 34725423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation on the inhibition of pyrrol-2-yl ethanone derivatives to lactate dehydrogenase and anticancer activities.
    Lu NN; Weng ZY; Chen QY; Boison D; Xiao XX; Gao J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Aug; 165():21-25. PubMed ID: 27104676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dimensional Analysis of the Interactions between hLDH5 and Its Inhibitors.
    Poli G; Granchi C; Aissaoui M; Minutolo F; Tuccinardi T
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29236080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line.
    Chen CY; Feng Y; Chen JY; Deng H
    Bioorg Med Chem Lett; 2016 Jan; 26(1):72-5. PubMed ID: 26597536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing the kinase field: new targets and second generation inhibitors.
    Laufer S; Bajorath J
    J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234
    [No Abstract]   [Full Text] [Related]  

  • 13. Small-molecule inhibitors of human LDH5.
    Granchi C; Paterni I; Rani R; Minutolo F
    Future Med Chem; 2013 Oct; 5(16):1967-91. PubMed ID: 24175747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of lactate dehydrogenase A (LDHA) in apo, ternary and inhibitor-bound forms.
    Kolappan S; Shen DL; Mosi R; Sun J; McEachern EJ; Vocadlo DJ; Craig L
    Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):185-95. PubMed ID: 25664730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel glyceraldehyde-3-phosphate dehydrogenase inhibitor via docking-based virtual screening.
    Li T; Tan X; Yang R; Miao Y; Zhang M; Xi Y; Guo R; Zheng M; Li B
    Bioorg Chem; 2020 Mar; 96():103620. PubMed ID: 32028064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Histone Lysine Demethylase LSD1/KDM1A as a New Avenue for Cancer Therapy.
    Fang Y; Liao G; Yu B
    Curr Top Med Chem; 2019; 19(11):889-891. PubMed ID: 31389779
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of novel human lactate dehydrogenase A inhibitors: High-throughput screening, synthesis, and biological evaluations.
    Zhou Y; Tao P; Wang M; Xu P; Lu W; Lei P; You Q
    Eur J Med Chem; 2019 Sep; 177():105-115. PubMed ID: 31129449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances at the intersection of chemical biology and medicinal chemistry.
    Tavassoli A
    Future Med Chem; 2015; 7(16):2089-90. PubMed ID: 26571116
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.
    Granchi C; Fortunato S; Meini S; Rizzolio F; Caligiuri I; Tuccinardi T; Lee HY; Hergenrother PJ; Minutolo F
    J Agric Food Chem; 2017 Jul; 65(28):5639-5649. PubMed ID: 28643510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Virtual Screening Study for Lactate Dehydrogenase 5 Inhibitors by Using a Pharmacophore-based Approach.
    Tuccinardi T; Poli G; Corchia I; Granchi C; Lapillo M; Macchia M; Minutolo F; Ortore G; Martinelli A
    Mol Inform; 2016 Sep; 35(8-9):434-9. PubMed ID: 27546047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.